Blepharoplasty belongs to the medical disciplines of oculoplastic surgery and plastic surgery. The fundamental clinical objective is to correct anatomical distortions of the anterior and middle eyelid lamellae caused by age-related tissue laxity, hereditary fat herniation, or structural neuromuscular weakness. By restoring the natural contours of the superior palpebral sulcus and the lower lid-cheek junction, blepharoplasty expands impaired peripheral vision, alleviates brow fatigue, and addresses periorbital asymmetry.

Blepharoplasty is conducted as an outpatient surgical procedure. Preoperative skin markings are applied with a fine-tip surgical marker while the patient sits upright, identifying excess cutaneous folds and natural anatomical creases. Local infiltration anesthesia (e.g., 2% lidocaine with 1:100,000 epinephrine) is administered to ensure complete analgesia and surgical hemostasis. For upper blepharoplasty, a skin or skin-muscle flap is excised using a scalpel, radiosurgical needle, or laser. If medial or central fat pads are herniated, the orbital septum is opened, and fat is either conservatively resected following micro-bipolar cautery or repositioned. Hemostasis is rigorously verified to prevent retrobulbar hematoma. Incisions are closed using fine non-absorbable (6-0 polypropylene or silk) or absorbable (6-0 fast-absorbing gut) sutures. Lower blepharoplasty utilizes either a transconjunctival approach (incision inside the lower lid to access fat pads without skin scars) or a transcutaneous subciliary approach (incision just below the eyelashes to address redundant skin and orbicularis laxity). Transconjunctival fat transposition secures herniated fat over the inferior orbital rim into the tear trough plane. Adjunctive lateral canthopexy or canthoplasty may be performed to stabilize horizontal lower lid laxity. Antibiotic ointment is applied to suture lines and the ocular surface prior to transfer to the recovery area.

Evidence-based clinical advantages of blepharoplasty documented in ophthalmic and plastic surgery literature include:

• Expansion of Superior Visual Fields: Goldmann and Humphrey visual perimetry demonstrate significant enlargement of upper and lateral peripheral visual fields following upper blepharoplasty (Hollander et al., 2019).
• Reduction of Eyestrain and Brow Fatigue: Eliminates chronic compensatory contraction of the frontalis muscle, alleviating tension headaches associated with upper lid hooding.
• Improved Ocular Surface Comfort: Corrects mechanical eyelash trichiasis caused by overhanging skin pushing cilia downward onto the cornea.
• Re-establishment of Periorbital Symmetry: Restores balanced palpebral fissure height, lid margin contour, and distinct superior palpebral folds.
• Restoration of Lower Eyelid Contour: Smooths the tear trough deformity and midface junction through transconjunctival or retro-septal fat repositioning (Saadat & Wise, 2018).

Blepharoplasty recovery follows a predictable biological tissue-healing timeline. During the first 48 hours, cold compress application minimizes acute inflammatory edema and capillary ooze. Sutures are removed between days 5 and 7. Periocular ecchymosis (bruising) typically resolves within 10 to 14 days, permitting return to non-strenuous professional activities. Light physical activity may resume at 2 weeks, whereas high-impact exercise, heavy lifting (>10 kg), and swimming are restricted until 4 weeks postoperatively. Full scar remodeling, tissue softening, and final lymphatic drainage resolution occur over 6 to 12 months.

Blepharoplasty addresses a spectrum of functional and structural periorbital conditions, including:

• Upper Eyelid Dermatochalasis: Excess, redundant upper lid skin hanging over the palpebral margin, causing visual field constriction.
• Orbital Fat Herniation: Weakening of the orbital septum causing central, medial, or lateral fat pad protrusion in upper or lower lids.
• Pseudoptosis: Apparent lowering of the upper eyelid margin caused by heavy, overhanging cutaneous tissue.
• Ectropion and Entropion: Eyelid margin malpositions associated with lower lid horizontal laxity (often addressed via concomitant canthoplasty).
• Periorbital Festoons and Malar Bags: Fluid or orbicularis muscle accumulation along the lower lid and malar complex.
• Brow Ptosis-Associated Hooding: Secondary superior eyelid crowding requiring differential diagnosis or adjunctive brow suspension.

Preoperative preparation for blepharoplasty requires a thorough ophthalmic and medical assessment. Patients must undergo a comprehensive eye examination, including tear film break-up time (TBUT) and Schirmer testing to screen for underlying dry eye disease. Automated visual field testing (perimetry) and high-resolution clinical photography are performed to document functional impairment for insurance or surgical baseline records. Patients are instructed to stop all aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), vitamin E, fish oil, and anticoagulant medications (such as warfarin, clopidogrel, or direct oral anticoagulants) 7 to 14 days before surgery under guidance from their prescribing physician. Strict smoking cessation is mandated for at least 4 weeks prior to and following surgery to ensure microvascular skin flap survival and minimize wound dehiscence. Patients fast from solid foods for 6 hours prior to procedures involving conscious sedation.

Blepharoplasty risks are stratified by severity and incidence. Common, self-limiting side effects include transient periocular edema, ecchymosis, mild lagophthalmos, chemosis (conjunctival swelling), and temporary tear film instability causing dryness or reflex epiphora. Less common complications include wound infection, suture granulomas, asymmetric eyelid creases, hyperpigmentation, or prolonged dry eye symptoms requiring aggressive lubrication. Serious but rare complications include lower lid ectropion or retraction due to excessive skin resection or anterior lamellar scarring, persistent lagophthalmos leading to corneal ulceration, and orbital hematoma with compartment syndrome leading to ischemic optic neuropathy and permanent visual loss (estimated incidence: 0.04%, according to Chang et al., 2017). Immediate surgical decompression via lateral canthotomy and cantholysis is required if orbital compartment syndrome occurs.

The clinical patient journey for blepharoplasty begins with an outpatient ophthalmic evaluation incorporating automated perimetry, tear film analysis, and palpebral fissure measurements. Preoperatively, patients discontinue antiplatelet and anticoagulant therapies under physician guidance. On the day of surgery, meticulous preoperative upright skin marking guides the incision. The procedure lasts 60 to 120 minutes under local or twilight anesthesia. Postoperatively, patients are monitored for 1 to 2 hours before discharge. Suture removal occurs at 5 to 7 days, with initial swelling subsiding within 14 days and final tissue scar maturation completing over 6 to 12 months.